Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Effects of Denosumab on Trabecular Bone Score and Femur Strength Index: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease): Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Longitudinal Follow-up of High School Athletes: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Follow-up of High School Athletes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02432183).
- Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02356211).
- Longitudinal Study of Dental Implant Therapy in HIV Positive Patients: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Study of Dental Implant Therapy in HIV Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01211288).
- Longitudinal Surveillance Registry (LSR) of ACUITY Spiral: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Surveillance Registry (LSR) of ACUITY Spiral: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00955708).
- Lopinavir/Ritonavir (Kaletra) PK in Children: Complete Statistical AnalysisIndependent statistical analysis of Lopinavir/Ritonavir (Kaletra) PK in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00810108).
- Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan: Complete Statistical AnalysisIndependent statistical analysis of Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Lorcaserin for Preventing Weight Gain Among Smokers: Complete Statistical AnalysisIndependent statistical analysis of Lorcaserin for Preventing Weight Gain Among Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02393547).
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LOSSIndependent statistical analysis of LOSS- Louisiana Obese Subjects Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00115063).
- Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue: Complete Statistical AnalysisIndependent statistical analysis of Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LOTIS-2Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- LOTIS-9Independent statistical analysis of A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL): primary endpoint results, effect estimate with confidence interval, sample-size…
- LOTUSIndependent statistical analysis of Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- LOTUSDIIndependent statistical analysis of A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LOUiSSeIndependent statistical analysis of A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome: primary endpoint results, effect estimate with confidence interval,…
- LOVARBIndependent statistical analysis of Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Lovastatin in Treating Patients At High Risk of Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Lovastatin in Treating Patients At High Risk of Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00462280).
- Lovaza® and Microvascular Function in Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Lovaza® and Microvascular Function in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00931879).
- Loving-Kindness Meditation for PTSD: Complete Statistical AnalysisIndependent statistical analysis of Loving-Kindness Meditation for PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01962714).
- LOVIT IIIndependent statistical analysis of Low Vision Intervention Trial II (LOVIT II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00958360).
- Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Low Cylinder Toric: Complete Statistical AnalysisIndependent statistical analysis of Low Cylinder Toric: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00732030).
- Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01428128).
- Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Low Dose Thymoglobin in Renal Transplant Patients: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Thymoglobin in Renal Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01280617).
- Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00970073).
- Low Dose Vasopressin in Traumatic Shock: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Vasopressin in Traumatic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00420407).
- Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Low Intensity Blood Flow Restriction Training Study: Complete Statistical AnalysisIndependent statistical analysis of Low Intensity Blood Flow Restriction Training Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03055260).
- Low Intensity Ultrasound Therapy for Upper Back Pain Relief: Complete Statistical AnalysisIndependent statistical analysis of Low Intensity Ultrasound Therapy for Upper Back Pain Relief: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02135094).
- Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management: Complete Statistical AnalysisIndependent statistical analysis of Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02129608).
- Low Nicotine Cigarettes Plus Electronic Cigarettes: Complete Statistical AnalysisIndependent statistical analysis of Low Nicotine Cigarettes Plus Electronic Cigarettes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058717).
- Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL): Complete Statistical AnalysisIndependent statistical analysis of Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings – Optimization Phase: Complete Statistical AnalysisIndependent statistical analysis of Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00082355).
- Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00113321).
- Low-dose IL-2( Interleukin-2) Treatment in SLE: Complete Statistical AnalysisIndependent statistical analysis of Low-dose IL-2( Interleukin-2) Treatment in SLE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02084238).
- Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01874951).
- Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia: primary endpoint results, effect estimate with confidence…
- Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3: primary endpoint results, effect estimate with confidence interval, sample-size planning…